Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2003
11/27/2003WO2003029459A3 Micro-rna molecules
11/27/2003WO2003028656A3 Adjuvant compositions
11/27/2003WO2003027669A3 Method for producing a normalized gene library from nucleic acid extracts of soil samples and the use thereof
11/27/2003WO2003027262A3 Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries
11/27/2003WO2003027147A3 Human coagulation factor vii polypeptides
11/27/2003WO2003026402A3 Carboxypeptidase n (cpn) disruptions compositions and methods relating thereto
11/27/2003WO2003023040A3 Vaccinia virus mva-e3l-knockout-mutants and use thereof
11/27/2003WO2003023027A3 Tt virus sequences in human tumoral tissue, agent for the detection thereof and tumoral therapy
11/27/2003WO2003023011A3 Antisense modulation of ribonuclease l expression
11/27/2003WO2003023005A3 Antisense modulation of pka regulatory subunit rii alpha expression
11/27/2003WO2003022868A3 Metal binding proteins and associated methods
11/27/2003WO2003020957A3 Use of fructose-1,6-bisphosphate aldolase for identifying novel substances having a fungicidal action
11/27/2003WO2003020759A3 A caspase- 8 binding protein, its preparation and use
11/27/2003WO2003018809A3 Isolation of proteins involved in posttranscriptional gene silencing and methods of use
11/27/2003WO2003018746A3 Estrogen receptor alpha variants and methods of detection thereof
11/27/2003WO2003018636A3 Chimaeric peptides of insulin, their compositions and use in treating diabetes
11/27/2003WO2003016481A3 Novel human collagen proteins and polynucleotides encoding the same
11/27/2003WO2003016342A3 Tumor antigens for prevention and/or treatment of cancer
11/27/2003WO2003013590A8 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer
11/27/2003WO2003012115A3 Dna molecules encoding herbicide tolerant acetolactate synthase
11/27/2003WO2003012064A3 Nucleic acids and encoded polypeptides associated with bipolar disorder
11/27/2003WO2003010200A3 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
11/27/2003WO2003009100A3 Methods, apparatuses, and computer programs for verifying the integrity of a probe
11/27/2003WO2003008443A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/27/2003WO2003006995A3 Method for identifying substances which modulate interleukin 4 (il-4) signaling
11/27/2003WO2003006611A3 GPCs AS MODIFIERS OF THE IRRTK AND p21 PATHWAYS AND METHODS OF USE
11/27/2003WO2003003810A3 Methods for detection and quantification of analytes in complex mixtures
11/27/2003WO2003000927A3 Method for the determination of telomere length
11/27/2003WO2002103046A3 Happier mapping
11/27/2003WO2002103008A3 Templated molecules and methods for using such molecules
11/27/2003WO2002102299A3 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
11/27/2003WO2002101079A3 Anti-apoptosis genes and methods of use thereof
11/27/2003WO2002099059A3 U5-200KDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
11/27/2003WO2002097097A3 Compositions and methods of increasing stress tolerance in plants
11/27/2003WO2002097075B1 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
11/27/2003WO2002094881A3 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/27/2003WO2002092801A3 Methods and compositions for making emamectin
11/27/2003WO2002092771A3 Specific binding proteins and uses thereof
11/27/2003WO2002092626A3 Cleavage and polyadenylation complex of precursor mrna
11/27/2003WO2002092004A8 Use of hmg fragment as anti-inflammatory agents
11/27/2003WO2002090586A3 Analytical method and kit
11/27/2003WO2002088361A3 Haemophilus influenzae antigens
11/27/2003WO2002086156A3 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
11/27/2003WO2002086128A3 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
11/27/2003WO2002086113A3 Enzyme and snp marker for disease
11/27/2003WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene
11/27/2003WO2002083924A3 Nucleic acid molecules relating to papaya ripening
11/27/2003WO2002083731A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/27/2003WO2002081632A3 Nucleic acids for transgene expression
11/27/2003WO2002081498A3 Novel proteins and nucleic acids encoding same
11/27/2003WO2002081490A3 Computer-directed assembly of a polynucleotide encoding a target polypeptide
11/27/2003WO2002079442A3 Transgenic mice containing ubiquitin enzyme gene disruptions
11/27/2003WO2002078730A3 Use of neublastin polypeptides for treating neuropathic pain
11/27/2003WO2002077272A3 Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders
11/27/2003WO2002077182A3 Compounds displayed on icosahedral phage and methods of using same
11/27/2003WO2002077164A3 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof
11/27/2003WO2002077030A3 Modified mhc molecules whose binding to cd8 or cd4 is inhibited and use thereof
11/27/2003WO2002074964A3 Polypeptides derived from rna polymerases and use thereof
11/27/2003WO2002072865A3 Methods, kits and compositions of combination oligomers
11/27/2003WO2002072838A3 A process for the fermentative preparation of d-pantothenic acid and/or its salts
11/27/2003WO2002072821A3 Method for indentification of cdnas encoding signal peptides
11/27/2003WO2002072632A3 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof.
11/27/2003WO2002070647A8 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses
11/27/2003WO2002068459A3 Non aggregating fluorescent proteins and methods for using the same
11/27/2003WO2002066617A8 Method for detecting a risk of hypertension and uses thereof
11/27/2003WO2002064805A3 Replication competent non-mammalian retroviral vectors
11/27/2003WO2002064801A8 Molecular control of transgene escape by a repressible excision system
11/27/2003WO2002064791A3 Proteins and nucleic acids encoding same
11/27/2003WO2002064624A8 Improved method for production of secreted proteins in fungi
11/27/2003WO2002063022A3 Plant regulatory sequences
11/27/2003WO2002063010A3 Method of producing recombinant antibodies against tumors
11/27/2003WO2002061109A3 Yeast strains autonomously producing steroids
11/27/2003WO2002060950B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
11/27/2003WO2002059324A3 Novel inositol polyphosphate kinase genes and uses thereof
11/27/2003WO2002057499A3 Mdr1 variants and methods for their use
11/27/2003WO2002052026A8 Nucleic acid integration in eukaryotes
11/27/2003WO2002050113A3 Interleukin-1 related gene and protein
11/27/2003WO2002049625A3 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/27/2003WO2002048368A3 Proteins associated with cell growth, differentiation, and death
11/27/2003WO2002048341A3 Knockout mice for a2d2 calcium ion channel subunit proteins
11/27/2003WO2002046424A3 Fibroblast growth factors
11/27/2003WO2002040662A3 Transgenic mice containing targeted gene disruptions
11/27/2003WO2001064875A9 Human transporter genes and proteins encoded thereby
11/27/2003US20030221224 Improving plant reproduction, propagation and yields via control of silk receptivity to pollen
11/27/2003US20030221223 Producing genetically engineerered human blood protein such as hemoglobin, antitrypsin, fibrinogen and thrombin in monocot plant seed; veterinary medicine
11/27/2003US20030221222 Plant retroviral polynucleotides and methods for use thereof
11/27/2003US20030221221 Preparing transgenic plant with increased growth rate, flowers and seed yield
11/27/2003US20030221220 Maize starch containing elevated amounts of actual amylose
11/27/2003US20030221219 Improving C3 plant photosynthetic activity via transformation with genes associated with C4 plant photosynthetic pathway
11/27/2003US20030221218 Bioengineering cotton fiber properties
11/27/2003US20030221217 Plant FAD2 coding sequence balancing for fatty acid profiling in edible oils
11/27/2003US20030221216 Wound-inducible expression in plants
11/27/2003US20030221215 Comprises nucleotide sequences for preventing oomycete infection of potato and/or tomato; disease resistant plants
11/27/2003US20030221214 Citrus tristeza virus resistance genes and methods of use
11/27/2003US20030221213 Using endogenous genetic elements to genetically enhance nutritional value and agronomic performance of plant without permanent or stable incorporation of unknown or foreign DNA into genome; reduction of freeze induced sweetening
11/27/2003US20030221212 Methods for large scale functional evaluation of nucleotide sequences in plants
11/27/2003US20030221211 Methods of suppressing gene expression
11/27/2003US20030221210 Method for introducing a gene into a plant using and adventitious bud redifferentiation gene under the control of a light-inducible promoter as a selectable marker gene, and vector for introducing a gene into a plant using the same
11/27/2003US20030221209 Modified proteinase inhibitors
11/27/2003US20030221208 Propagating transgenic animal cells via transfering genetically engineered stem cells into a blastocoel and allowing genetic exchange with subsequent grafting into womb of female recipient